Applix customer GTC Biotherapeutics wins 'Best Model'

Biotech Leader's Applix TM1 Business Model Application Provides Tangible Business Benefits; Southeast Corporate FCU Also Recognized

WESTBOROUGH, Mass., Sept. 20, 2005 -- Applix, Inc. (Nasdaq: APLX), a global provider of single platform solutions for Business Performance Management (BPM) and Business Intelligence (BI), today announced the results of its first annual business modeling contest. Entries were judged on business impact, technological innovation and presentation quality. The most important criteria was measurable ROI, including top- or bottom-line improvements, increased customer satisfaction, growth in market share, faster time-to-market and faster month-end closing cycles.

GTC Biotherapeutics, Inc. (Nasdaq: GTCB, "GTC"), also the recent recipient of the Start Magazine 2005 Technology & Business Award, took top honors in the Applix Best TM1 Model Contest, with Southeast Corporate Federal Credit Union, headquartered in Tallahassee, Florida, receiving an honorable mention. GTC's application, based on Applix's TM1(R) BPM suite helps GTC manage programs for commercializing therapeutic proteins. Southeast Corporate FCU's solution was focused on consolidating its business performance management activities onto a single platform for all financial, operational analysis, and reporting to management and regulatory bodies.

"Businesses need tangible enhancements in their performance and that's what Applix's TM1 helps them deliver," said David Menninger, vice president of worldwide marketing and product management, Applix, Inc. "All of our customers are able to quickly and easily demonstrate bottom-line business value, but both GTC and Southeast Corporate have sophisticated models with multiple applications that drive top-line and bottom-line improvements as well as market share growth. Their applications fully leverage TM1's capabilities and, in some cases, make use of real-time, on-demand calculations not available through any other OLAP tool."

"GTC uses TM1 to plan, budget, perform activity-based costing (ABC), determine variances, and to execute Sarbanes-Oxley compliance activities," said James Kneece, senior director, Finance and Planning, GTC Biotherapeutics. "Because of its inherent flexibility, we knew that TM1 could be rapidly deployed and provide quick return on investment, and that has quickly proven to be true."

"Applix offered us a powerful system for financial reporting, budgeting, forecasting, daily updates, ad hoc reporting, and regulatory reporting activities," said Dan McGowan, Southeast Corporate vice president, Financial, Reporting and Analysis. "But the key to our business success was TM1's user- friendly environment that enables our team to fully utilize the system and allows us to quickly and easily makes changes when needed."

Additional information on GTC's application can be found at

Additional information on Southeast Corporate can be found at

About GTC

GTC Biotherapeutics is a leader in the development, production, and commercialization of therapeutic proteins through transgenic animal technology. GTC currently has five products in its internal pipeline and a portfolio of external program production opportunities. GTC's lead program is ATryn(R), its recombinant form of human antithrombin. A Market Authorization Application is under review by the European Medicines Agency for the use of ATryn(R) in patients with a hereditary antithrombin deficiency. In addition to the ATryn(R) program, GTC is developing a recombinant human alpha-1 antitrypsin, a recombinant human albumin, a malaria vaccine, and a CD137 antibody to stimulate the immune system as a potential treatment for solid tumors. In its external programs, GTC's technology is used to develop transgenic production of its partners' proprietary products, including both large-volume protein therapeutics as well as products that are difficult to produce in significant quantities from conventional recombinant production systems. One of the external programs is in clinical trials with a transgenically produced product. Additional information is available on the GTC web site,

About Southeast Corporate

Southeast Corporate Federal Credit Union (, headquartered in Tallahassee, Florida, has a mission to provide comprehensive financial services and solutions to credit unions that meet or exceed its members' changing needs and expectations. With approximately $4 billion in assets, Southeast Corporate serves almost 470 member credit unions, concentrated in Florida and the Southeastern states. Southeast Corporate is one of the highest rated financial institutions in the country, as reflected by its AA rating from Standard & Poor's.

Applix TM1

Applix's TM1 is a proven, multi-dimensional business planning, reporting and analytics platform for powering strategic analysis of financial, transactional, operational and other business data. TM1 has scored the highest rating in goal achievement, better decisions, and better reporting for the second year in a row, according to The OLAP Survey 4 ( by independent analyst Nigel Pendse. The annual BPM Partners "Beyond the Hype" Webcast ( named Applix the 2004 leader in the tools category and in 2005 recognized that Applix customers had the highest level of satisfaction of any of the leading BPM solutions, suites, tools and vendors. Customers using TM1-based applications have won industry awards from several leading publications, including Start Magazine and Business Finance Magazine.

Applix recently released TM1 Financial Consolidations(TM) to streamline journal entries, inter-company eliminations and other consolidation processes. The company also offers TM1 Planning Manager(TM) to provide workflow and compliance capabilities for all TM1-based applications, TM1 Financial Reporting(TM) for rapid and easy reporting applications and TM1 Web(TM), a Web-enabled front end for global and remote read/write capabilities of BPM and BI applications.

About Applix

Applix (Nasdaq: APLX) is a global provider of Business Performance Management and Business Intelligence solutions. These solutions, based on Applix's TM1 analytics platform, enable the continuous planning, management and monitoring of performance across the financial and operational functions within the enterprise. Applix is a founder of the BPM Standards Group (, and has been recognized by numerous industry analyst groups for its technical leadership and vision in the marketplace.

More than 2,000 customers worldwide use TM1 for its tight integration with Excel, real-time response, adaptability, and low total cost of ownership. Delivered by Applix and by a global network of partners, TM1-based solutions help customers manage their business performance and respond to the marketplace in real time. Headquartered in Westborough, MA, Applix maintains offices in four countries in Europe, North America and the Pacific Rim. For more information about Applix, please visit

This news release contains forward-looking statements that involve risks and uncertainties. Forward-looking statements in this document are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements concerning future plans or results are only estimates and actual results could differ materially from expectations. Certain factors that could cause or contribute to such differences include without limitation, competitive pressures, changes in customer demands, adverse economic conditions, loss of key personnel, litigation, potential fluctuations in quarterly results, lengthy sales cycles, market acceptance of new or enhanced products and services, factors affecting spending by customers and other risks, uncertainties and factors including those described in the Company's Annual Report on Form 10-K for the year ended December 31, 2004 under the heading "Risk Factors" and its most recent Quarterly Report on Form 10-Q under the heading "Factors That May Affect Future Results." The forward-looking statements provided by the Company in this press release represent the Company's views as of the date of this release. The Company anticipates that subsequent events and developments may cause the Company's views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so, and these forward- looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of this release.

Applix and TM1 are registered trademarks of Applix, Inc. TM1 Financial Consolidations, TM1 Planning Manager, and TM1 Web are trademarks of Applix, Inc. All other trademarks and company names mentioned are the property of their respective owners.

Charlotte Locke                            

DSS Home |  About Us |  Contact Us |  Site Index |  Subscribe | What's New
Please Tell 
Your Friends about DSSResources.COM Copyright © 1995-2021 by D. J. Power (see his home page). DSSResources.COMsm was maintained by Daniel J. Power. See disclaimer and privacy statement.